Oligonucleotides are short DNA or RNA molecules, oligomers, that have a wide range of applications in genetic testing, research, and forensics. Commonly made in the laboratory by solid-phase chemical synthesis, these small bits of nucleic acids can be manufactured as single-stranded molecules with any user-specified sequence, and so are vital for artificial gene synthesis, polymerase chain reaction (PCR), DNA sequencing, library construction and as molecular probes.
Oligonucleotide therapeutics have attracted drug manufacturers to guarantee lower drug advancement costs, and the capacity to achieve targets that are not achieved by traditional small molecule drugs. Various clinical candidates have progressed, and a few drugs seem balanced for regulatory approvals. Large pharmaceutical organizations appear to once again investing and putting resources into oligonucleotides through authorizing licensing deals, partnerships, and acquisitions.

Market Analysis and Insights: Global Oligonucleotide Pool Market
The global Oligonucleotide Pool market size is projected to reach US$ 2707.5 million by 2027, from US$ 1765.9 million in 2020, at a CAGR of 5.8% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oligonucleotide Pool market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oligonucleotide Pool market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oligonucleotide Pool market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oligonucleotide Pool market.

Global Oligonucleotide Pool Scope and Market Size
Oligonucleotide Pool market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oligonucleotide Pool market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
DNA Pool
RNA Pool

Segment by Application
Diagnostics
Therapeutics
Research
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Agilent Technologies
Creative Biogene
CustomArray
Integrated DNA Technologies
MYcroarray
Sigma Aldrich
TriLink BioTechnologies
Twist Bioscience